Table 3.
The status of axillary lymph node (ALN) after neoadjuvant chemotherapy in group B
ALN | Non-sentinel node | Total | |
---|---|---|---|
Positive | Negative | ||
Sentinel node | |||
Positive | 14 | 11 | 25 |
Negative | 3 | 26 | 29 |
Total | 17 | 37 | 54 |
False negative rate 10.7 % (3/(25 + 3);95 % CI, 2–28 %),Overall accuracy 94.4 % ((25 + 26)/54;95 % CI, 88–99 %),Sensitivity rate 89.3 % (25/(25 + 3);95 % CI, 72–98 %)